
Paul M. Yonover, MD, FACS, offers closing thoughts on unmet needs and clinical challenges surrounding the treatment of prostate cancer.

Paul M. Yonover, MD, FACS, offers closing thoughts on unmet needs and clinical challenges surrounding the treatment of prostate cancer.

An expert on prostate cancer discusses treatment considerations for patients with high-risk prostate cancer who have high disease burden and other comorbidities.

A urology specialist reviews the case of a 78-year-old patient with metastatic prostate cancer, analyzes their risk level and prognosis, and discusses frontline treatment.

Paul M. Yonover, MD, FACS, reviews treatment options available for patients with high-risk prostate cancer following radical prostatectomy.

A comprehensive overview of treatment options available for patients with prostate cancer and factors that influence treatment decisions.

An expert on prostate cancer discusses the clinical application of imaging and biomarker testing for patients with prostate cancer.

Paul M. Yonover, MD, FACS, a urology specialist, reviews the case of a 66-year-old man with prostate cancer and offers his initial impressions.

Recent data support the product’s use in protecting organs at risk for radiation exposure.

Published: September 22nd 2023 | Updated:

Published: September 22nd 2023 | Updated:

Published: September 22nd 2023 | Updated:

Published: September 22nd 2023 | Updated:

Published: September 22nd 2023 | Updated:

Published: September 22nd 2023 | Updated: